1. Zhou, Xueya, Feliciano, Pamela, Shu, Chang, Shen, Yufeng, Chung, Wendy K. 2022. Integrating de novo and inherited variants in 42,607 autism cases identifies mutations in new moderate-risk genes. In Nature genetics, 54, 1305-1319. doi:10.1038/s41588-022-01148-2. https://pubmed.ncbi.nlm.nih.gov/35982159/
2. Lei, Yining, Zhang, Ruyi, Cai, Fei. 2024. Role of MARK2 in the nervous system and cancer. In Cancer gene therapy, 31, 497-506. doi:10.1038/s41417-024-00737-z. https://pubmed.ncbi.nlm.nih.gov/38302729/
3. Aghabozorg Afjeh, Sara Sadat, Shams, Jamal, Hamednia, Safar, Omrani, Amin, Omrani, Mir Davood. 2022. Validating MARK2 Gene Polymorphism as a Predictor of Response to Lithium Treatment in Bipolar Patients. In Iranian biomedical journal, 26, 110-5. doi:10.52547/ibj.26.2.110. https://pubmed.ncbi.nlm.nih.gov/34953473/
4. Zeng, Yongji, Yin, Ling, Zhou, Jiuli, Chen, Yuanhong, Dong, Jixin. 2022. MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer. In Oncogene, 41, 3859-3875. doi:10.1038/s41388-022-02399-3. https://pubmed.ncbi.nlm.nih.gov/35780183/
5. Wei, Xianfu, Xu, Liang, Jeddo, Salim Fa, Li, Xin, Li, Jianmin. 2020. MARK2 enhances cisplatin resistance via PI3K/AKT/NF-κB signaling pathway in osteosarcoma cells. In American journal of translational research, 12, 1807-1823. doi:. https://pubmed.ncbi.nlm.nih.gov/32509178/
6. Caiola, Hanna O, Wu, Qian, Soni, Shaili, Wagner, George C, Zhang, Huaye. 2023. Neuronal connectivity, behavioral, and transcriptional alterations associated with the loss of MARK2. In bioRxiv : the preprint server for biology, , . doi:10.1101/2023.12.05.569759. https://pubmed.ncbi.nlm.nih.gov/38105965/
智鼠故事 
